Global Male Hypogonadism Market Size, Status and Forecast 2020-2026

May 2020 | 93 pages | ID: G3EC35C2488AEN
QYResearch

Abstracts

This report focuses on the global Male Hypogonadism status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Male Hypogonadism development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

• Astrazeneca Plc.
• Merck & Co. Inc.
• Laboratories Genevrier
• Allergan Plc.
• Endo International Plc.
• Ferring
• AbbVie Inc.
• Eli Lilly and Company Ltd.
• Finox Biotech
• Teva Pharmaceutical Industries Ltd.
• Bayer AG
• IBSA Institut Biochimque

Market segment by Type, the product can be split into

• Testosterone Replacement Therapy
• Gonadotropin-Releasing Hormones Therapy

Market segment by Application, split into

• Kallmann Syndrome
• Klinefelters Syndrome
• Pituitary Disorders
• Others

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Male Hypogonadism status, future forecast, growth opportunity, key market and key players.
• To present the Male Hypogonadism development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Male Hypogonadism are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Male Hypogonadism Revenue
1.4 Market Analysis by Type
  1.4.1 Global Male Hypogonadism Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Testosterone Replacement Therapy
  1.4.3 Gonadotropin-Releasing Hormones Therapy
1.5 Market by Application
  1.5.1 Global Male Hypogonadism Market Share by Application: 2020 VS 2026
  1.5.2 Kallmann Syndrome
  1.5.3 Klinefelters Syndrome
  1.5.4 Pituitary Disorders
  1.5.5 Others
1.6 Study Objectives
1.7 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Male Hypogonadism Market Perspective (2015-2026)
2.2 Male Hypogonadism Growth Trends by Regions
  2.2.1 Male Hypogonadism Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Male Hypogonadism Historic Market Share by Regions (2015-2020)
  2.2.3 Male Hypogonadism Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Male Hypogonadism Market Growth Strategy
  2.3.6 Primary Interviews with Key Male Hypogonadism Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Male Hypogonadism Players by Market Size
  3.1.1 Global Top Male Hypogonadism Players by Revenue (2015-2020)
  3.1.2 Global Male Hypogonadism Revenue Market Share by Players (2015-2020)
  3.1.3 Global Male Hypogonadism Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Male Hypogonadism Market Concentration Ratio
  3.2.1 Global Male Hypogonadism Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Male Hypogonadism Revenue in 2019
3.3 Male Hypogonadism Key Players Head office and Area Served
3.4 Key Players Male Hypogonadism Product Solution and Service
3.5 Date of Enter into Male Hypogonadism Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Male Hypogonadism Historic Market Size by Type (2015-2020)
4.2 Global Male Hypogonadism Forecasted Market Size by Type (2021-2026)

5 MALE HYPOGONADISM BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Male Hypogonadism Market Size by Application (2015-2020)
5.2 Global Male Hypogonadism Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Male Hypogonadism Market Size (2015-2020)
6.2 Male Hypogonadism Key Players in North America (2019-2020)
6.3 North America Male Hypogonadism Market Size by Type (2015-2020)
6.4 North America Male Hypogonadism Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Male Hypogonadism Market Size (2015-2020)
7.2 Male Hypogonadism Key Players in Europe (2019-2020)
7.3 Europe Male Hypogonadism Market Size by Type (2015-2020)
7.4 Europe Male Hypogonadism Market Size by Application (2015-2020)

8 CHINA

8.1 China Male Hypogonadism Market Size (2015-2020)
8.2 Male Hypogonadism Key Players in China (2019-2020)
8.3 China Male Hypogonadism Market Size by Type (2015-2020)
8.4 China Male Hypogonadism Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Male Hypogonadism Market Size (2015-2020)
9.2 Male Hypogonadism Key Players in Japan (2019-2020)
9.3 Japan Male Hypogonadism Market Size by Type (2015-2020)
9.4 Japan Male Hypogonadism Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Male Hypogonadism Market Size (2015-2020)
10.2 Male Hypogonadism Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Male Hypogonadism Market Size by Type (2015-2020)
10.4 Southeast Asia Male Hypogonadism Market Size by Application (2015-2020)

11 INDIA

11.1 India Male Hypogonadism Market Size (2015-2020)
11.2 Male Hypogonadism Key Players in India (2019-2020)
11.3 India Male Hypogonadism Market Size by Type (2015-2020)
11.4 India Male Hypogonadism Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Male Hypogonadism Market Size (2015-2020)
12.2 Male Hypogonadism Key Players in Central & South America (2019-2020)
12.3 Central & South America Male Hypogonadism Market Size by Type (2015-2020)
12.4 Central & South America Male Hypogonadism Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Astrazeneca Plc.
  13.1.1 Astrazeneca Plc. Company Details
  13.1.2 Astrazeneca Plc. Business Overview and Its Total Revenue
  13.1.3 Astrazeneca Plc. Male Hypogonadism Introduction
  13.1.4 Astrazeneca Plc. Revenue in Male Hypogonadism Business (2015-2020))
  13.1.5 Astrazeneca Plc. Recent Development
13.2 Merck & Co. Inc.
  13.2.1 Merck & Co. Inc. Company Details
  13.2.2 Merck & Co. Inc. Business Overview and Its Total Revenue
  13.2.3 Merck & Co. Inc. Male Hypogonadism Introduction
  13.2.4 Merck & Co. Inc. Revenue in Male Hypogonadism Business (2015-2020)
  13.2.5 Merck & Co. Inc. Recent Development
13.3 Laboratories Genevrier
  13.3.1 Laboratories Genevrier Company Details
  13.3.2 Laboratories Genevrier Business Overview and Its Total Revenue
  13.3.3 Laboratories Genevrier Male Hypogonadism Introduction
  13.3.4 Laboratories Genevrier Revenue in Male Hypogonadism Business (2015-2020)
  13.3.5 Laboratories Genevrier Recent Development
13.4 Allergan Plc.
  13.4.1 Allergan Plc. Company Details
  13.4.2 Allergan Plc. Business Overview and Its Total Revenue
  13.4.3 Allergan Plc. Male Hypogonadism Introduction
  13.4.4 Allergan Plc. Revenue in Male Hypogonadism Business (2015-2020)
  13.4.5 Allergan Plc. Recent Development
13.5 Endo International Plc.
  13.5.1 Endo International Plc. Company Details
  13.5.2 Endo International Plc. Business Overview and Its Total Revenue
  13.5.3 Endo International Plc. Male Hypogonadism Introduction
  13.5.4 Endo International Plc. Revenue in Male Hypogonadism Business (2015-2020)
  13.5.5 Endo International Plc. Recent Development
13.6 Ferring
  13.6.1 Ferring Company Details
  13.6.2 Ferring Business Overview and Its Total Revenue
  13.6.3 Ferring Male Hypogonadism Introduction
  13.6.4 Ferring Revenue in Male Hypogonadism Business (2015-2020)
  13.6.5 Ferring Recent Development
13.7 AbbVie Inc.
  13.7.1 AbbVie Inc. Company Details
  13.7.2 AbbVie Inc. Business Overview and Its Total Revenue
  13.7.3 AbbVie Inc. Male Hypogonadism Introduction
  13.7.4 AbbVie Inc. Revenue in Male Hypogonadism Business (2015-2020)
  13.7.5 AbbVie Inc. Recent Development
13.8 Eli Lilly and Company Ltd.
  13.8.1 Eli Lilly and Company Ltd. Company Details
  13.8.2 Eli Lilly and Company Ltd. Business Overview and Its Total Revenue
  13.8.3 Eli Lilly and Company Ltd. Male Hypogonadism Introduction
  13.8.4 Eli Lilly and Company Ltd. Revenue in Male Hypogonadism Business (2015-2020)
  13.8.5 Eli Lilly and Company Ltd. Recent Development
13.9 Finox Biotech
  13.9.1 Finox Biotech Company Details
  13.9.2 Finox Biotech Business Overview and Its Total Revenue
  13.9.3 Finox Biotech Male Hypogonadism Introduction
  13.9.4 Finox Biotech Revenue in Male Hypogonadism Business (2015-2020)
  13.9.5 Finox Biotech Recent Development
13.10 Teva Pharmaceutical Industries Ltd.
  13.10.1 Teva Pharmaceutical Industries Ltd. Company Details
  13.10.2 Teva Pharmaceutical Industries Ltd. Business Overview and Its Total Revenue
  13.10.3 Teva Pharmaceutical Industries Ltd. Male Hypogonadism Introduction
  13.10.4 Teva Pharmaceutical Industries Ltd. Revenue in Male Hypogonadism Business (2015-2020)
  13.10.5 Teva Pharmaceutical Industries Ltd. Recent Development
13.11 Bayer AG
  10.11.1 Bayer AG Company Details
  10.11.2 Bayer AG Business Overview and Its Total Revenue
  10.11.3 Bayer AG Male Hypogonadism Introduction
  10.11.4 Bayer AG Revenue in Male Hypogonadism Business (2015-2020)
  10.11.5 Bayer AG Recent Development
13.12 IBSA Institut Biochimque
  10.12.1 IBSA Institut Biochimque Company Details
  10.12.2 IBSA Institut Biochimque Business Overview and Its Total Revenue
  10.12.3 IBSA Institut Biochimque Male Hypogonadism Introduction
  10.12.4 IBSA Institut Biochimque Revenue in Male Hypogonadism Business (2015-2020)
  10.12.5 IBSA Institut Biochimque Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Male Hypogonadism Key Market Segments
Table 2. Key Players Covered: Ranking by Male Hypogonadism Revenue
Table 3. Ranking of Global Top Male Hypogonadism Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Male Hypogonadism Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Testosterone Replacement Therapy
Table 6. Key Players of Gonadotropin-Releasing Hormones Therapy
Table 7. Global Male Hypogonadism Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Male Hypogonadism Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Male Hypogonadism Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Male Hypogonadism Market Share by Regions (2015-2020)
Table 11. Global Male Hypogonadism Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Male Hypogonadism Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Male Hypogonadism Market Growth Strategy
Table 17. Main Points Interviewed from Key Male Hypogonadism Players
Table 18. Global Male Hypogonadism Revenue by Players (2015-2020) (Million US$)
Table 19. Global Male Hypogonadism Market Share by Players (2015-2020)
Table 20. Global Top Male Hypogonadism Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Male Hypogonadism as of 2019)
Table 21. Global Male Hypogonadism by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Male Hypogonadism Product Solution and Service
Table 24. Date of Enter into Male Hypogonadism Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Male Hypogonadism Market Size by Type (2015-2020) (Million US$)
Table 27. Global Male Hypogonadism Market Size Share by Type (2015-2020)
Table 28. Global Male Hypogonadism Revenue Market Share by Type (2021-2026)
Table 29. Global Male Hypogonadism Market Size Share by Application (2015-2020)
Table 30. Global Male Hypogonadism Market Size by Application (2015-2020) (Million US$)
Table 31. Global Male Hypogonadism Market Size Share by Application (2021-2026)
Table 32. North America Key Players Male Hypogonadism Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Male Hypogonadism Market Share (2019-2020)
Table 34. North America Male Hypogonadism Market Size by Type (2015-2020) (Million US$)
Table 35. North America Male Hypogonadism Market Share by Type (2015-2020)
Table 36. North America Male Hypogonadism Market Size by Application (2015-2020) (Million US$)
Table 37. North America Male Hypogonadism Market Share by Application (2015-2020)
Table 38. Europe Key Players Male Hypogonadism Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Male Hypogonadism Market Share (2019-2020)
Table 40. Europe Male Hypogonadism Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Male Hypogonadism Market Share by Type (2015-2020)
Table 42. Europe Male Hypogonadism Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Male Hypogonadism Market Share by Application (2015-2020)
Table 44. China Key Players Male Hypogonadism Revenue (2019-2020) (Million US$)
Table 45. China Key Players Male Hypogonadism Market Share (2019-2020)
Table 46. China Male Hypogonadism Market Size by Type (2015-2020) (Million US$)
Table 47. China Male Hypogonadism Market Share by Type (2015-2020)
Table 48. China Male Hypogonadism Market Size by Application (2015-2020) (Million US$)
Table 49. China Male Hypogonadism Market Share by Application (2015-2020)
Table 50. Japan Key Players Male Hypogonadism Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Male Hypogonadism Market Share (2019-2020)
Table 52. Japan Male Hypogonadism Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Male Hypogonadism Market Share by Type (2015-2020)
Table 54. Japan Male Hypogonadism Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Male Hypogonadism Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Male Hypogonadism Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Male Hypogonadism Market Share (2019-2020)
Table 58. Southeast Asia Male Hypogonadism Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Male Hypogonadism Market Share by Type (2015-2020)
Table 60. Southeast Asia Male Hypogonadism Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Male Hypogonadism Market Share by Application (2015-2020)
Table 62. India Key Players Male Hypogonadism Revenue (2019-2020) (Million US$)
Table 63. India Key Players Male Hypogonadism Market Share (2019-2020)
Table 64. India Male Hypogonadism Market Size by Type (2015-2020) (Million US$)
Table 65. India Male Hypogonadism Market Share by Type (2015-2020)
Table 66. India Male Hypogonadism Market Size by Application (2015-2020) (Million US$)
Table 67. India Male Hypogonadism Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Male Hypogonadism Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Male Hypogonadism Market Share (2019-2020)
Table 70. Central & South America Male Hypogonadism Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Male Hypogonadism Market Share by Type (2015-2020)
Table 72. Central & South America Male Hypogonadism Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Male Hypogonadism Market Share by Application (2015-2020)
Table 74. Astrazeneca Plc. Company Details
Table 75. Astrazeneca Plc. Business Overview
Table 76. Astrazeneca Plc. Product
Table 77. Astrazeneca Plc. Revenue in Male Hypogonadism Business (2015-2020) (Million US$)
Table 78. Astrazeneca Plc. Recent Development
Table 79. Merck & Co. Inc. Company Details
Table 80. Merck & Co. Inc. Business Overview
Table 81. Merck & Co. Inc. Product
Table 82. Merck & Co. Inc. Revenue in Male Hypogonadism Business (2015-2020) (Million US$)
Table 83. Merck & Co. Inc. Recent Development
Table 84. Laboratories Genevrier Company Details
Table 85. Laboratories Genevrier Business Overview
Table 86. Laboratories Genevrier Product
Table 87. Laboratories Genevrier Revenue in Male Hypogonadism Business (2015-2020) (Million US$)
Table 88. Laboratories Genevrier Recent Development
Table 89. Allergan Plc. Company Details
Table 90. Allergan Plc. Business Overview
Table 91. Allergan Plc. Product
Table 92. Allergan Plc. Revenue in Male Hypogonadism Business (2015-2020) (Million US$)
Table 93. Allergan Plc. Recent Development
Table 94. Endo International Plc. Company Details
Table 95. Endo International Plc. Business Overview
Table 96. Endo International Plc. Product
Table 97. Endo International Plc. Revenue in Male Hypogonadism Business (2015-2020) (Million US$)
Table 98. Endo International Plc. Recent Development
Table 99. Ferring Company Details
Table 100. Ferring Business Overview
Table 101. Ferring Product
Table 102. Ferring Revenue in Male Hypogonadism Business (2015-2020) (Million US$)
Table 103. Ferring Recent Development
Table 104. AbbVie Inc. Company Details
Table 105. AbbVie Inc. Business Overview
Table 106. AbbVie Inc. Product
Table 107. AbbVie Inc. Revenue in Male Hypogonadism Business (2015-2020) (Million US$)
Table 108. AbbVie Inc. Recent Development
Table 109. Eli Lilly and Company Ltd. Business Overview
Table 110. Eli Lilly and Company Ltd. Product
Table 111. Eli Lilly and Company Ltd. Company Details
Table 112. Eli Lilly and Company Ltd. Revenue in Male Hypogonadism Business (2015-2020) (Million US$)
Table 113. Eli Lilly and Company Ltd. Recent Development
Table 114. Finox Biotech Company Details
Table 115. Finox Biotech Business Overview
Table 116. Finox Biotech Product
Table 117. Finox Biotech Revenue in Male Hypogonadism Business (2015-2020) (Million US$)
Table 118. Finox Biotech Recent Development
Table 119. Teva Pharmaceutical Industries Ltd. Company Details
Table 120. Teva Pharmaceutical Industries Ltd. Business Overview
Table 121. Teva Pharmaceutical Industries Ltd. Product
Table 122. Teva Pharmaceutical Industries Ltd. Revenue in Male Hypogonadism Business (2015-2020) (Million US$)
Table 123. Teva Pharmaceutical Industries Ltd. Recent Development
Table 124. Bayer AG Company Details
Table 125. Bayer AG Business Overview
Table 126. Bayer AG Product
Table 127. Bayer AG Revenue in Male Hypogonadism Business (2015-2020) (Million US$)
Table 128. Bayer AG Recent Development
Table 129. IBSA Institut Biochimque Company Details
Table 130. IBSA Institut Biochimque Business Overview
Table 131. IBSA Institut Biochimque Product
Table 132. IBSA Institut Biochimque Revenue in Male Hypogonadism Business (2015-2020) (Million US$)
Table 133. IBSA Institut Biochimque Recent Development
Table 134. Research Programs/Design for This Report
Table 135. Key Data Information from Secondary Sources
Table 136. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Male Hypogonadism Market Share by Type: 2020 VS 2026
Figure 2. Testosterone Replacement Therapy Features
Figure 3. Gonadotropin-Releasing Hormones Therapy Features
Figure 4. Global Male Hypogonadism Market Share by Application: 2020 VS 2026
Figure 5. Kallmann Syndrome Case Studies
Figure 6. Klinefelters Syndrome Case Studies
Figure 7. Pituitary Disorders Case Studies
Figure 8. Others Case Studies
Figure 9. Male Hypogonadism Report Years Considered
Figure 10. Global Male Hypogonadism Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Male Hypogonadism Market Share by Regions: 2020 VS 2026
Figure 12. Global Male Hypogonadism Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Male Hypogonadism Market Share by Players in 2019
Figure 15. Global Top Male Hypogonadism Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Male Hypogonadism as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Male Hypogonadism Revenue in 2019
Figure 17. North America Male Hypogonadism Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Male Hypogonadism Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Male Hypogonadism Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Male Hypogonadism Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Male Hypogonadism Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Male Hypogonadism Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Male Hypogonadism Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Astrazeneca Plc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. Astrazeneca Plc. Revenue Growth Rate in Male Hypogonadism Business (2015-2020)
Figure 26. Merck & Co. Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Merck & Co. Inc. Revenue Growth Rate in Male Hypogonadism Business (2015-2020)
Figure 28. Laboratories Genevrier Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Laboratories Genevrier Revenue Growth Rate in Male Hypogonadism Business (2015-2020)
Figure 30. Allergan Plc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Allergan Plc. Revenue Growth Rate in Male Hypogonadism Business (2015-2020)
Figure 32. Endo International Plc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Endo International Plc. Revenue Growth Rate in Male Hypogonadism Business (2015-2020)
Figure 34. Ferring Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Ferring Revenue Growth Rate in Male Hypogonadism Business (2015-2020)
Figure 36. AbbVie Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. AbbVie Inc. Revenue Growth Rate in Male Hypogonadism Business (2015-2020)
Figure 38. Eli Lilly and Company Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Eli Lilly and Company Ltd. Revenue Growth Rate in Male Hypogonadism Business (2015-2020)
Figure 40. Finox Biotech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Finox Biotech Revenue Growth Rate in Male Hypogonadism Business (2015-2020)
Figure 42. Teva Pharmaceutical Industries Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Male Hypogonadism Business (2015-2020)
Figure 44. Bayer AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. Bayer AG Revenue Growth Rate in Male Hypogonadism Business (2015-2020)
Figure 46. IBSA Institut Biochimque Total Revenue (US$ Million): 2019 Compared with 2018
Figure 47. IBSA Institut Biochimque Revenue Growth Rate in Male Hypogonadism Business (2015-2020)
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed